7 Root Causes of Mast Cell Activation Syndrome Explained

Mast cell activation syndrome (MCAS) can produce a bewildering array of symptoms, from hives and flushing to gastrointestinal distress and, in severe cases, anaphylaxis. People searching for the 7 root causes of mast cell activation syndrome are usually trying to make sense of complex, multi-system symptoms — but it is important to start with an honest frame: MCAS is a real but relatively rare condition that is currently over-diagnosed, and the factors often labeled “root causes” are, for the most part, proposed associations and areas of research rather than proven, treatable causes. When mast cells genuinely become hyperreactive, they can release excessive histamine, prostaglandins, leukotrienes, and other mediators into surrounding tissue, causing symptoms across several organ systems. Understanding what is — and is not — established is the first step toward getting an accurate evaluation.

What Are Mast Cells, and What Is MCAS?

Mast cells are immune cells found in connective tissues throughout the body, especially in the skin, gut lining, airways, and around blood vessels. Their normal job is to detect threats — pathogens, allergens, and toxins — and mount a rapid inflammatory response. When working properly, they are essential for wound healing, fighting infection, and coordinating immune defense.

In true mast cell activation disorders, these cells release their mediators inappropriately, either in response to stimuli that should not provoke such a strong reaction or, less commonly, without a clear trigger. But an over-reactive symptom does not automatically equal MCAS. Many common conditions — ordinary allergies, chronic hives (chronic spontaneous urticaria), carcinoid and other rare tumors, thyroid disease, dysautonomia, anxiety with physical symptoms, and gastrointestinal disorders — can produce overlapping complaints. That is precisely why MCAS is a diagnosis of careful evaluation, not a label to apply to any multi-system illness.

How MCAS Is Actually Diagnosed

According to consensus criteria published in the allergy/immunology literature (often called the “consensus-2” criteria), a diagnosis of MCAS generally requires all three of the following:

• Episodic, recurrent symptoms consistent with mast cell mediator release affecting two or more organ systems (for example, skin plus gastrointestinal plus cardiovascular).
• An objective, transient rise in a validated mast cell mediator measured during or shortly after an episode. Serum tryptase is the best-validated marker: experts look for a rise of at least a defined percentage above the person’s own baseline plus a small fixed amount (the widely cited “20% + 2 ng/mL” rule), drawn within a few hours of an event and compared with a baseline level.
• A response to treatments that target mast cells or their mediators (such as antihistamines or other mast-cell-directed therapy chosen by a clinician).

These criteria are deliberately strict, and this is where over-diagnosis happens: many people are told they have “MCAS” on the basis of symptoms alone, or on unvalidated tests, without ever documenting an objective mediator rise. Random urinary or blood “mediator panels” collected without proper timing and handling, food-specific IgG “sensitivity” tests, hair analysis, and commercial “MCAS panels” are not validated ways to diagnose MCAS. A board-certified allergist/immunologist is the appropriate specialist; the workup typically includes a baseline tryptase, careful history, and ruling out mimics and related mast cell diseases (such as systemic mastocytosis, which is diagnosed differently). Treat the numbers above as background on how specialists think — not thresholds to self-apply.

A Note Before the “7 Root Causes”

The sections that follow describe factors that researchers and clinicians have associated with mast cell reactivity, or hypothesized might contribute to it. They are presented here because readers ask about them — but they are best understood as areas of ongoing research and proposed mechanisms, not a validated checklist of causes you can test for and cure. Association is not causation, much of the supporting evidence is preliminary or drawn from laboratory and animal studies, and identifying one of these factors does not confirm MCAS or replace proper diagnosis. Be especially wary of any program that markets these as your personal “root cause” and sells testing, supplements, or “detox” as the fix.

1. Genetic Factors: KIT Variants and Hereditary Alpha-Tryptasemia

The clearest genetic story in mast cell biology involves the KIT gene, which encodes a receptor important for mast cell development and activation. The D816V KIT mutation is the hallmark of systemic mastocytosis — a distinct condition from MCAS — and researchers continue to study whether other genetic variants lower the threshold for mast cell activation more broadly.

Hereditary alpha-tryptasemia (HaT), caused by extra copies of the TPSAB1 gene that encodes alpha-tryptase, is a well-characterized trait associated with elevated baseline tryptase and, in some people, symptoms such as flushing and multi-system complaints. NIH researchers have estimated HaT is present in a meaningful minority of the general population (often cited around 4 to 7 percent). Importantly, HaT is common and having it — or a somewhat high baseline tryptase — does not by itself mean a person has MCAS. It is one piece of context a specialist weighs, not a diagnosis.

2. Infections and Immune Dysregulation (Proposed)

Some infections and post-infectious states have been studied in connection with mast cell reactivity, though the strength of the evidence varies widely and much remains unproven.

Viral and post-viral illness: There is legitimate scientific interest in whether viral infections, including SARS-CoV-2, can influence mast cell behavior, and mast cell activation has been proposed as one possible contributor to some post-viral (“long COVID”) symptoms. This is an active research area, not a settled mechanism.

Claims to treat with more caution: The idea that chronic “Lyme co-infections” (such as Bartonella or Babesia), “mold and biotoxin illness,” or small intestinal bacterial overgrowth (SIBO) are common drivers of MCAS is controversial and not well established. These narratives are frequently used by clinics that sell extensive unvalidated testing and long courses of supplements or antimicrobials. If you are being told your MCAS is caused by mold or a chronic hidden infection, seek an evaluation from a mainstream allergist/immunologist before pursuing costly, unproven protocols.

3. Gut Barrier and Digestive Health (Proposed)

The gut contains a large share of the body’s mast cells, and researchers have studied links between intestinal inflammation and mast cell activity. Studies in irritable bowel syndrome (IBS), for example, have observed increased mast cell numbers and activation in the intestinal mucosa correlating with symptom severity.

However, the popular concept of “leaky gut” as a discrete, testable diagnosis is not a validated clinical entity, and the notion that “healing the gut” with specific supplement protocols cures MCAS is unproven. Gut symptoms are worth taking seriously and evaluating with a gastroenterologist, but be cautious about commercial “intestinal permeability” tests and elaborate supplement regimens marketed as MCAS cures.

4. Environmental Exposures (Mostly Preliminary Evidence)

Various environmental exposures — heavy metals, certain pesticides, volatile organic compounds, and endocrine-disrupting chemicals such as BPA — have been shown in laboratory or animal studies to influence mast cell behavior. This is interesting mechanistic research, but it is a long way from establishing that everyday exposures cause MCAS in people, and it does not justify chelation, “heavy-metal detox,” or similar interventions.

Some people with mast cell symptoms report sensitivity to strong fragrances or chemicals. Reasonable steps — improving ventilation, reducing exposure to known irritants, avoiding personal triggers — are sensible and low-risk. Aggressive “detox” programs, chelation therapy, and expensive toxin panels are not evidence-based treatments for MCAS and can carry real risks.

5. Connective Tissue Disorders and the hEDS-POTS Overlap (Observed Association)

Clinicians have observed that some patients present with a cluster of hypermobile Ehlers-Danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), and mast cell symptoms. This overlap is frequently discussed in clinical literature, and it is reasonable for a specialist to consider each condition when the others are present.

That said, the mechanism linking connective tissue disorders to mast cell activation is not understood, and even the strength of the association is debated among experts. Proposed explanations — abnormal collagen affecting the tissue environment, or shared genetic predisposition — remain hypotheses. The practical takeaway is simply that if you have hEDS or POTS and also have objective mast cell findings, an allergist/immunologist can help sort out whether MCAS is truly part of the picture.

6. Stress and the Nervous System (Plausible, Still Being Defined)

There is genuine science behind bidirectional communication between nerves and mast cells: mast cells often sit near nerve endings, and neuropeptides such as substance P and corticotropin-releasing hormone can influence mast cell activity. Research also suggests psychological stress can affect mast cells in the gut and elsewhere. This makes stress a plausible modulator of symptoms for some people.

What is not established is that “nervous system dysregulation” is a root cause of MCAS that can be fixed with any single technique. Stress management, good sleep, and trauma-informed mental health care are worthwhile for overall well-being and may help symptom burden, but they should complement — not replace — proper medical evaluation. Be cautious of programs that sell “vagus nerve” devices or brain-retraining courses as cures.

7. Hormonal Influences (Associations, Especially in Women)

Mast cells can respond to hormones, and clinicians have long noted that mast cell symptoms are reported more often in women and sometimes fluctuate with the menstrual cycle, pregnancy, or menopause. Laboratory research has explored how estrogen may enhance, and progesterone may generally calm, mast cell activity, which could help explain why some women notice cyclical patterns.

A rare, distinct condition called progesterone hypersensitivity does exist and can cause cyclical allergic-type reactions; it requires specialist evaluation. Thyroid disease and adrenal/HPA-axis problems can also cause symptoms that overlap with mast cell complaints. The sensible approach is to have genuine hormonal or thyroid problems evaluated on their own terms, rather than assuming they are the “root cause” of MCAS.

Frequently Asked Questions

Can MCAS be cured by addressing “root causes”?

There is no evidence that MCAS is cured by chasing the proposed factors above with testing, supplements, or “detox.” MCAS, when genuinely present, is generally managed as a chronic condition with clinician-directed strategies (such as trigger avoidance and mast-cell-directed medications), not eliminated by a root-cause program. Some people do improve when a genuinely co-existing problem — a real allergy, a thyroid disorder, or true progesterone hypersensitivity, for example — is properly treated. The safest path is evaluation by an allergist/immunologist rather than an out-of-pocket “root cause” clinic.

How is MCAS different from mastocytosis?

Mastocytosis involves an abnormal proliferation (increase in number) of mast cells, usually driven by the D816V KIT mutation, and is diagnosed through specific testing including bone marrow evaluation and criteria set by pathology. MCAS, by contrast, refers to mast cells that are typically normal in number but activating inappropriately, diagnosed using the clinical-plus-mediator criteria described earlier. Both can cause symptoms from mediator release, but they are distinct diagnoses evaluated in different ways.

Why am I being told I have MCAS when my allergist is skeptical?

This is common and reflects genuine debate. Because MCAS symptoms are nonspecific, it is easy to over-apply the label, and some practices diagnose it liberally on symptoms alone. A cautious allergist/immunologist is not dismissing you — they are trying to document an objective mediator rise and rule out mimics before settling on a diagnosis, which protects you from unnecessary treatments. Seeking a second opinion from a board-certified specialist is reasonable.

What are common triggers for people with genuine mast cell activation?

Reported triggers vary by individual and may include certain foods, heat, physical exertion, stress, strong fragrances, insect stings, and some medications (such as NSAIDs or opioids in susceptible people). Keeping a symptom diary can help identify personal patterns. Any medication changes to avoid triggers should be discussed with a clinician, and anyone at risk of anaphylaxis should have an emergency plan.

Can children have mast cell disorders?

Mast cell disorders can affect people of all ages, though pediatric presentations differ and diagnosis is challenging because symptoms overlap with common childhood conditions. Pediatric allergists/immunologists with experience in mast cell disorders are the appropriate specialists. As with adults, caution about unvalidated testing and “root cause” marketing applies.

Key Takeaways

MCAS is a real condition, but it is relatively rare and currently over-diagnosed, and the “7 root causes” people search for are better understood as proposed associations and research directions than as validated, curable causes. Formal diagnosis is strict: episodic multi-system symptoms, an objective rise in a validated mediator such as tryptase during an episode, and a response to mast-cell-targeted treatment — assessed by a board-certified allergist/immunologist who also rules out the many mimics. Be skeptical of clinics, unvalidated lab panels, and supplement or “detox” programs that promise to find and fix your “root cause.” Above all, treat anaphylaxis as an emergency: use prescribed epinephrine and call 911. For a broader look at related conditions, visit our medical conditions guide. This article is educational only and is not a substitute for care from a qualified clinician.

Sources

• American Academy of Allergy, Asthma & Immunology (AAAAI) — mast cell activation syndrome overview and diagnostic guidance
• Valent P, Akin C, et al. — consensus criteria for MCAS (diagnostic criteria and the tryptase “20% + 2 ng/mL” rule), Journal of Allergy and Clinical Immunology (via PubMed)
• National Institute of Allergy and Infectious Diseases (NIAID/NIH) — mast cell disorders and hereditary alpha-tryptasemia
• MedlinePlus (U.S. National Library of Medicine) — anaphylaxis